Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPfizer Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 9 | $0.61 | $0.81 | $0.72 |
| Q2 2025 | 4 | $0.57 | $0.57 | $0.57 |
| Q3 2025 | 4 | $0.92 | $0.92 | $0.92 |
| Q4 2025 | 7 | $0.77 | $0.77 | $0.77 |
| Q1 2026 | 7 | $0.80 | $0.80 | $0.80 |
| Q2 2026 | 3 | $0.60 | $0.60 | $0.60 |
| Q3 2026 | 3 | $0.96 | $0.96 | $0.96 |
| Q4 2026 | 7 | $0.72 | $0.72 | $0.72 |
Pfizer Inc. Earnings Date And Information
Pfizer Inc. last posted its earnings results on Tuesday, February 4th, 2025. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.4716 by $0.1584. The company had revenue of 17.76 B for the quarter and had revenue of 63.63 B for the year. Pfizer Inc. has generated $1 earnings per share over the last year ($1.41 diluted earnings per share) and currently has a price-to-earnings ratio of 17.7. Pfizer Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based on prior year's report dates.
Pfizer Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 2024 | N/A | $0.07 | N/A | $17.35 B | $17.76 B |
| 11/04/2024 | Q3 2024 | N/A | $0.79 | N/A | N/A | $17.70 B |
| 08/05/2024 | Q2 2024 | N/A | $0.00 | N/A | $12.96 B | $13.28 B |
| 05/08/2024 | Q1 2024 | N/A | $0.55 | N/A | $13.87 B | $14.88 B |
| 02/22/2024 | Q4 2023 | N/A | -$0.59 | N/A | $14.37 B | $14.25 B |
| 11/08/2023 | Q3 2023 | N/A | -$0.42 | N/A | N/A | $13.23 B |
| 08/09/2023 | Q2 2023 | N/A | $0.41 | N/A | N/A | $12.73 B |
| 05/10/2023 | Q1 2023 | N/A | $0.98 | N/A | N/A | $18.28 B |
| 02/23/2023 | Q4 2022 | N/A | $0.89 | N/A | N/A | $24.29 B |
| 11/09/2022 | Q3 2022 | N/A | $1.54 | N/A | N/A | $22.64 B |
| 08/10/2022 | Q2 2022 | N/A | $1.77 | N/A | N/A | $27.74 B |
| 05/11/2022 | Q1 2022 | N/A | $1.40 | N/A | N/A | $25.66 B |
| 02/24/2022 | Q4 2021 | N/A | $0.60 | N/A | $24.16 B | $23.84 B |
| 11/12/2021 | Q3 2021 | N/A | $1.45 | N/A | N/A | $24.09 B |
| 08/12/2021 | Q2 2021 | N/A | $0.99 | N/A | N/A | $18.98 B |
| 05/13/2021 | Q1 2021 | N/A | $0.87 | N/A | N/A | $14.58 B |
| 02/25/2021 | Q4 2020 | N/A | $0.11 | N/A | $11.67 B | $11.68 B |
| 11/05/2020 | Q3 2020 | N/A | $0.39 | N/A | N/A | $12.13 B |
| 08/06/2020 | Q2 2020 | N/A | $0.63 | N/A | N/A | $11.80 B |
| 05/07/2020 | Q1 2020 | N/A | $0.60 | N/A | $11.81 B | $12.03 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pfizer Inc. Earnings: FAQ's
Pfizer Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based offlast year's report dates.
In the previous quarter, Pfizer Inc. (:PFE) reported $0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $0.4716 by $0.1584.
The conference call for Pfizer Inc.'s latest earnings report can be listened to online.
The conference call transcript for Pfizer Inc.'s latest earnings report can be read online.
Pfizer Inc. (:PFE) has a recorded annual revenue of $63.63 B.
Pfizer Inc. (:PFE) has a recorded net income of $8.03 B.Pfizer Inc. has generated $1.42 earnings per share over the last four quarters.
Pfizer Inc. (:PFE) has a price-to-earnings ratio of 17.7 and price/earnings-to-growth ratio is 0.2.